中国药师
中國藥師
중국약사
CHINA PHARMACIST
2014年
4期
678-681,682
,共5页
林小明%韦宝含%曾毅%韦平原%梁汉钦%谢伟乾%陈明忠
林小明%韋寶含%曾毅%韋平原%樑漢欽%謝偉乾%陳明忠
림소명%위보함%증의%위평원%량한흠%사위건%진명충
硝普钠%高效液相色谱法%配伍%稳定性
硝普鈉%高效液相色譜法%配伍%穩定性
초보납%고효액상색보법%배오%은정성
Sodium nitroprusside%HPLC%Compatibility%Stability
目的:评价注射用硝普钠在2种输液(氯化钠注射液、5%葡萄糖注射液)中的稳定性。方法:将注射用硝普钠按临床应用浓度配制成A、B、C、D四组溶液,考察不同环境条件下,不同放置时间硝普钠溶液的稳定性,包括溶液外观、不溶性微粒、pH、紫外-可见吸收光谱、硝普钠含量等。结果:在避光条件下,在20℃或35℃时,硝普钠与5%葡萄糖注射液或氯化钠注射液的配伍后26 h内是稳定的;在不用或用避光套避光且强光照射时,硝普钠溶液极不稳定。结论:氯化钠注射液和5%葡萄糖注射液均可作为注射用硝普钠的溶媒,且溶液在26 h内稳定。临床配制或使用硝普钠注射液时,要严格避光,才能保证用药安全有效。
目的:評價註射用硝普鈉在2種輸液(氯化鈉註射液、5%葡萄糖註射液)中的穩定性。方法:將註射用硝普鈉按臨床應用濃度配製成A、B、C、D四組溶液,攷察不同環境條件下,不同放置時間硝普鈉溶液的穩定性,包括溶液外觀、不溶性微粒、pH、紫外-可見吸收光譜、硝普鈉含量等。結果:在避光條件下,在20℃或35℃時,硝普鈉與5%葡萄糖註射液或氯化鈉註射液的配伍後26 h內是穩定的;在不用或用避光套避光且彊光照射時,硝普鈉溶液極不穩定。結論:氯化鈉註射液和5%葡萄糖註射液均可作為註射用硝普鈉的溶媒,且溶液在26 h內穩定。臨床配製或使用硝普鈉註射液時,要嚴格避光,纔能保證用藥安全有效。
목적:평개주사용초보납재2충수액(록화납주사액、5%포도당주사액)중적은정성。방법:장주사용초보납안림상응용농도배제성A、B、C、D사조용액,고찰불동배경조건하,불동방치시간초보납용액적은정성,포괄용액외관、불용성미립、pH、자외-가견흡수광보、초보납함량등。결과:재피광조건하,재20℃혹35℃시,초보납여5%포도당주사액혹록화납주사액적배오후26 h내시은정적;재불용혹용피광투피광차강광조사시,초보납용액겁불은정。결론:록화납주사액화5%포도당주사액균가작위주사용초보납적용매,차용액재26 h내은정。림상배제혹사용초보납주사액시,요엄격피광,재능보증용약안전유효。
Objective:To evaluate the compatible stability of sodium nitroprusside for injection ( SNP) in two kinds of solutions (5% glucose and sodium chloride injections) . Methods:A, B, C and D solution of SNP was respectively prepared according to the concentration of clinical use. The stability of SNP solution was studied in different environment with different storing time, and the as-sessment indices included the appearance, insoluble particles, pH value, ultraviolet-visible absorption spectrum and SNP content. Re-sults:The SNP solutions in 5% glucose and sodium chloride injections were stable in 26 hours in photophobic condition at 20℃ and 35℃. Under an incandescent lamp with or without lightproof, the solutions were very unstable. Conclusion:Both sodium chloride and 5% glucose injections can be used as the solvent for SNP with 26h stability. SNP injections prepared and used in clinics should be pre-served away from light to ensure the safety and effectiveness.